Overview
Portfolio
More
Accelmed
Miami, United States
Focuses on acquiring and investing in U.S. commercial‑stage HealthTech companies, leveraging industry expertise to improve patient outcomes, reduce costs and increase efficiency across medical devices, diagnostics, digit...
Portfolio
35+
Employees
10+
Founded
2009
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Accelmed
Focuses on acquiring and investing in U.S. commercial‑stage HealthTech companies, leveraging industry expertise to improve patient outcomes, reduce costs and increase efficiency across medical devices, diagnostics, digital health and tech‑enabled services.
Portfolio
35+
Employees
10+
Founded
2009
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 14 of 14 matched portfolio companies
Axonius is an asset inventory management platform that aggregates and normalizes data from various sources to provide a real-time inventory of all digital assets, including devices, identities, and software. This enables IT and security teams to identify vulnerabilities, automate remediation actions, and enhance their overall cybersecurity posture.
Funding: $595.1M
Rough estimate of the amount of funding raised
Funding: $595.1M
Rough estimate of the amount of funding raised
The startup offers a platform for paid companionship and intimacy, featuring an end-to-end booking system that enhances user safety through verified profiles and secure payment processing. This service addresses the stigma surrounding companionship by providing a legitimate and structured approach to connecting clients with companions in various locations.
Provides a subscription-based jewelry rental service offering fine and demi-fine pieces, allowing customers to access a rotating collection without the high cost of ownership. Utilizes a circular economy model by recycling and repurposing old jewelry to reduce waste and create new items, promoting sustainability in the fashion industry.
Click Therapeutics develops FDA‑cleared, prescription‑only digital therapeutics delivered via mobile apps that can be used alone or combined with drugs as Software‑Enhanced Drugs™. Leveraging neuroscience, AI‑driven personalization, and digital biomarkers, its platform modulates neurocircuitry to improve efficacy, adherence, and outcomes for neurological, psychiatric, and chronic conditions. The solution integrates with electronic health records, providing clinicians with evidence‑based reports while offering patients engaging, clinically validated interventions on their smartphones.
Digma Medical offers the Endoscopic Gastrointestinal Ablation Device (EGAD), a balloon‑catheter system that delivers near‑infrared laser energy for uniform, depth‑controlled ablation of Barrett’s Esophagus tissue. The single‑use, through‑the‑scope catheter integrates with standard GI endoscopes, provides real‑time imaging‑guided mapping, and eliminates the need for fluoroscopy, general anesthesia, or additional hardware, enabling outpatient treatment.
GT Medical Technologies offers GammaTile Therapy, a surgically targeted radiation treatment for patients with operable brain tumors, which is placed at the time of tumor resection. This technology minimizes radiation exposure to healthy tissue, reduces side effects, and ensures 100% treatment compliance, ultimately delaying tumor recurrence and potentially extending patient survival.
Funding: $110.2M
Rough estimate of the amount of funding raised
Funding: $110.2M
Rough estimate of the amount of funding raised
LOOP utilizes AI technology, big data analytics, and telematics to develop insurance products that are priced more equitably. By analyzing diverse data sources, the company aims to provide fairer premiums for consumers while enhancing risk assessment for insurers.
Funding: $32.3M
Rough estimate of the amount of funding raised
Funding: $32.3M
Rough estimate of the amount of funding raised
NeuroPace has developed the RNS® System, the only FDA-approved device that utilizes responsive neurostimulation to monitor and respond to abnormal brain activity in patients with drug-resistant focal epilepsy. This technology provides personalized treatment by delivering targeted stimulation based on a patient's unique seizure patterns, significantly reducing seizure frequency and improving quality of life.
Nitinotes has developed the EndoZip™, an automated endoscopic suturing system that delivers precise restrictive sutures to the stomach wall for obesity treatment. This minimally invasive solution provides a safe and effective alternative for over 700 million patients with obesity class I and II who are not candidates for traditional bariatric surgery, achieving an average total body weight loss of 13.5% after 12 months.
Funding: $9.3M
Rough estimate of the amount of funding raised
Funding: $9.3M
Rough estimate of the amount of funding raised
O is developing an IoT device that visualizes the human circadian clock to enhance individual and organizational performance through data-driven insights. The platform provides actionable recommendations based on sleep data, addressing productivity issues and mental health risks within teams.
Funding: $7.1M
Rough estimate of the amount of funding raised
Funding: $7.1M
Rough estimate of the amount of funding raised
RA UNLIMITED harnesses solar photovoltaic technology to generate clean and affordable electricity for homes, businesses, and communities in the Philippines. The company addresses the reliance on fossil fuels by providing sustainable energy solutions that create jobs and enhance the quality of life for Filipinos.
Provides a financial navigation platform that integrates with EMR, pharmacy, and practice management systems to identify and match patients with over 6,000 financial assistance resources, including copay cards and government programs. By streamlining enrollment processes and projecting out-of-pocket costs, it reduces financial barriers to treatment, improving access and affordability for patients across all conditions.
Funding: $73.1M
Rough estimate of the amount of funding raised
Funding: $73.1M
Rough estimate of the amount of funding raised
UltraClear Laser provides an advanced skin resurfacing platform using proprietary cold fiber laser technology for precise ablation and dermal remodeling. Its 3DMIRACL® and Laser-Coring™ technologies effectively treat wrinkles, scars, and pigmentation across all skin types with minimal downtime and discomfort.
Vie integrates direct deposits with a financial ecosystem combining a senior credit facility, a dividend-paying investment account, and a secured credit card. The system uses a loan to immediately fund a life insurance policy that generates compounding dividends to automatically service the debt. This structure allows users to maintain consumer spending habits while building investment equity through automated financial cycles.
Showing 12 of 21 unmatched portfolio companies